
Mat Angelos
@mat_angelos
Leukemia & Cell Therapy/Transplant faculty @CUHematology | Physician-scientist | Previously @PennCancer @PennIMResidents @UMNMSTP @DukeU
ID: 966431232522416128
21-02-2018 21:55:36
15 Tweet
117 Takipçi
185 Takip Edilen



Check out our phase 1 CAR-M study in progress at the Developmental Therapeutics session Sunday AM. Excited to meet you at 327b and discuss other new cell therapy work at #ASCO2022 Kim Reiss Binder (Kim Reiss)

Check out some recent updates and our viewpoints for using CAR-T in T-cell leukemias/lymphomas. Great review to prep to #ASH23! Marco Ruella @StefanBartaMD Ruchi Patel sciencedirect.com/science/articl…

Mat Angelos from our Ruella Lab presenting for the for the first time a novem CD2 deleted CART2 for T-ALL: High preclinical efficacy against primary leukemias #ASH23 Penn Medicine


Congrats Puneeth Guruprasad on leading this fantastic work. Looking forward to seeing this evolve into the clinic!

Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models. Penn Medicine Ruella Lab science.org/doi/10.1126/sc…

Grateful to #ASH2024 for the chance to present our work on overcoming the absence of CD2:CD58 co-stimulation using an innovative PD1:iCD2 switch receptor. Thanks to my mentor Marco Ruella and the Ruella Lab for their invaluable support. Excited to delve deeper into this approach!



